Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
98.12
+3.31 (3.49%)
Nov 21, 2024, 1:35 PM EST - Market open
Blueprint Medicines Market Cap
Blueprint Medicines has a market cap or net worth of $6.23 billion as of November 21, 2024. Its market cap has increased by 69.14% in one year.
Market Cap
6.23B
Enterprise Value
5.87B
1-Year Change
69.14%
Ranking
Category
Stock Price
$98.12
Market Cap Chart
Since April 30, 2015, Blueprint Medicines's market cap has increased from $469.40M to $6.23B, an increase of 1,227.90%. That is a compound annual growth rate of 31.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 6.02B | 7.41% |
| Dec 29, 2023 | 5.61B | 113.92% |
| Dec 30, 2022 | 2.62B | -58.41% |
| Dec 31, 2021 | 6.30B | 0.83% |
| Dec 31, 2020 | 6.25B | 58.57% |
| Dec 31, 2019 | 3.94B | 66.35% |
| Dec 31, 2018 | 2.37B | -19.85% |
| Dec 29, 2017 | 2.96B | 285.69% |
| Dec 30, 2016 | 766.50M | 7.38% |
| Dec 31, 2015 | 713.80M | 52.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elanco Animal Health | 6.58B |
| Nuvalent | 6.47B |
| Merit Medical Systems | 6.10B |
| R1 RCM | 6.04B |
| Cytokinetics | 6.03B |
| RadNet | 5.91B |
| Viking Therapeutics | 5.74B |
| Halozyme Therapeutics | 5.70B |